It’s been a chaotic three years for Masimo CEO Joe Kiani.
First came the pandemic, and with it, a dramatic uptick in demand for Masimo’s pulse oximetry devices. Then came the patient monitoring company’s 2022 acquisition of Sound United, a consumer audio business, which perplexed investors and sent Masimo stocks crumbling. At the same time, Masimo has launched a coordinated legal battle against Apple, alleging the tech giant stole trade secrets to use in the Apple Watch. The latest effort ended in a mistrial last week.
“To have a hung jury surprised me. I did not see that coming. We think it was unusual jury dynamics. We don’t think that will happen again. And we’re gonna go back and retry it,” Kiani told STAT.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect